A detailed history of Costello Asset Management, Inc transactions in Cel Sci Corp stock. As of the latest transaction made, Costello Asset Management, Inc holds 3,100 shares of CVM stock, worth $2,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,100
Previous 3,100 -0.0%
Holding current value
$2,573
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$2.58 - $4.99 $5,160 - $9,980
2,000 Added 181.82%
3,100 $14,000
Q2 2021

Aug 05, 2021

SELL
$8.68 - $27.49 $572 - $1,814
-66 Reduced 5.66%
1,100 $10,000
Q1 2021

May 03, 2021

BUY
$12.0 - $27.64 $1,992 - $4,588
166 Added 16.6%
1,166 $18,000
Q2 2020

Jul 28, 2020

BUY
$9.75 - $17.6 $9,750 - $17,600
1,000 New
1,000 $15,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $36M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Costello Asset Management, Inc Portfolio

Follow Costello Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Costello Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Costello Asset Management, Inc with notifications on news.